Patents by Inventor Nelson Scarborough
Nelson Scarborough has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11160512Abstract: A monitoring system is disclosed for in vivo monitoring of preselected physiological parameters associated with acute and/or chronic tissue compromise or failure in one or multiple tissue/organ sites in real time. In one method, a body portion of a surgical stapling device is positioned adjacent a first tissue section, an anvil assembly adapted to engage the body portion is positioned adjacent a second tissue section, and a monitoring device is positioned adjacent the first and/or second tissue sections. The monitoring device includes a sensor adapted to measure a preselected physiological parameter and a transmitter for transmitting signal to an extracorporeal receiving unit. The surgical stapling device is fired to mechanically secure the first and second tissue sections with at least one staple and the preselected physiological parameter is monitored via the information transmitted from the monitoring device to the receiving unit.Type: GrantFiled: May 12, 2017Date of Patent: November 2, 2021Assignee: COVIDIEN LPInventors: Yong Ma, Nelson Scarborough, Marisha Godek, Rohan Shah, James Power, Nilay Mukherjee, Frank Viola, Edward Mckenna, Shannon Campbell
-
Patent number: 10441679Abstract: In certain described embodiments, implantable medical materials comprise a scaffolding material, a liquid organic binder, and entrapped calcium-containing particles. The medical materials can incorporate an osteoinductive factor such as a protein. The scaffolding material can bind the factor. In additional described embodiments, implantable medical materials include an osteoconductive scaffolding material, an incorporated osteoinductive factor, and a biodegradable barrier material effective to delay release of the factor from the scaffolding material. The scaffolding material can bind the factor. Also described a methods for preparing and implanting the described medical materials.Type: GrantFiled: September 12, 2018Date of Patent: October 15, 2019Assignee: WARSAW ORTHOPEDIC, INC.Inventors: Jeffrey M. Gross, Steve Peckham, Jeffrey L. Scifert, Jeffrey Badura, Nelson Scarborough, Scott Vickers
-
Publication number: 20190009001Abstract: In certain described embodiments, implantable medical materials comprise a scaffolding material, a liquid organic binder, and entrapped calcium-containing particles. The medical materials can incorporate an osteoinductive factor such as a protein. The scaffolding material can bind the factor. In additional described embodiments, implantable medical materials include an osteoconductive scaffolding material, an incorporated osteoinductive factor, and a biodegradable barrier material effective to delay release of the factor from the scaffolding material. The scaffolding material can bind the factor. Also described a methods for preparing and implanting the described medical materials.Type: ApplicationFiled: September 12, 2018Publication date: January 10, 2019Inventors: Jeffrey M. Gross, Steve Peckham, Jeffrey L. Scifert, Jeffrey Badura, Nelson Scarborough, Scott Vickers
-
Patent number: 10080819Abstract: In certain described embodiments, implantable medical materials comprise a scaffolding material, a liquid organic binder, and entrapped calcium-containing particles. The medical materials can incorporate an osteoinductive factor such as a protein. The scaffolding material can bind the factor. In additional described embodiments, implantable medical materials include an osteoconductive scaffolding material, an incorporated osteoinductive factor, and a biodegradable barrier material effective to delay release of the factor from the scaffolding material. The scaffolding material can bind the factor. Also described a methods for preparing and implanting the described medical materials.Type: GrantFiled: May 15, 2015Date of Patent: September 25, 2018Assignee: Warsaw Orthopedic, IncInventors: Jeffrey M. Gross, Steve Peckham, Jeffrey L. Scifert, Jeffrey Badura, Nelson Scarborough, Scott Vickers
-
Publication number: 20170245809Abstract: A monitoring system is disclosed for in vivo monitoring of preselected physiological parameters associated with acute and/or chronic tissue compromise or failure in one or multiple tissue/organ sites in real time. In one method, a body portion of a surgical stapling device is positioned adjacent a first tissue section, an anvil assembly adapted to engage the body portion is positioned adjacent a second tissue section, and a monitoring device is positioned adjacent the first and/or second tissue sections. The monitoring device includes a sensor adapted to measure a preselected physiological parameter and a transmitter for transmitting signal to an extracorporeal receiving unit. The surgical stapling device is fired to mechanically secure the first and second tissue sections with at least one staple and the preselected physiological parameter is monitored via the information transmitted from the monitoring device to the receiving unit.Type: ApplicationFiled: May 12, 2017Publication date: August 31, 2017Inventors: Yong Ma, Nelson Scarborough, Marisha Godek, Rohan Shah, James Power, Nilay Mukherjee, Frank Viola, Edward Mckenna, Shannon Campbell
-
Patent number: 9744124Abstract: Flowable compositions and methods are provided for delivering a therapeutic agent at or near a target tissue site beneath the skin of a patient, the flowable composition comprising (i) a solvent and (ii) an effective amount of the therapeutic agent, the flowable composition being capable of hardening to form a drug depot at a physiological temperature or as solvent contacts bodily fluid at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutic agent over a period of at least one day and the target tissue site comprises at least one muscle, ligament, tendon, cartilage, spinal disc, spinal foraminal space near the spinal nerve root, facet or synovial joint, or spinal canal.Type: GrantFiled: October 19, 2015Date of Patent: August 29, 2017Assignee: Warsaw Orthopedic, Inc.Inventors: Susan J. Drapeau, William F. McKay, Nelson Scarborough
-
Patent number: 9649113Abstract: A monitoring system is disclosed for in vivo monitoring of preselected physiological parameters associated with acute and/or chronic tissue compromise or failure in one or multiple tissue/organ sites in real time. In one method, a body portion of a surgical stapling device is positioned adjacent a first tissue section, an anvil assembly adapted to engage the body portion is positioned adjacent a second tissue section, and a monitoring device is positioned adjacent the first and/or second tissue sections. The monitoring device includes a sensor adapted to measure a preselected physiological parameter and a transmitter for transmitting signal to an extracorporeal receiving unit. The surgical stapling device is fired to mechanically secure the first and second tissue sections with at least one staple and the preselected physiological parameter is monitored via the information transmitted from the monitoring device to the receiving unit.Type: GrantFiled: April 3, 2012Date of Patent: May 16, 2017Assignee: Covidien LPInventors: Yong Ma, Nelson Scarborough, Marisha Godek, Rohan Shah, James Power, Nilay Mukherjee, Frank Viola, Edward McKenna, Shannon Campbell
-
Publication number: 20160038407Abstract: Flowable compositions and methods are provided for delivering a therapeutic agent at or near a target tissue site beneath the skin of a patient, the flowable composition comprising (i) a solvent and (ii) an effective amount of the therapeutic agent, the flowable composition being capable of hardening to form a drug depot at a physiological temperature or as solvent contacts bodily fluid at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutic agent over a period of at least one day and the target tissue site comprises at least one muscle, ligament, tendon, cartilage, spinal disc, spinal foraminal space near the spinal nerve root, facet or synovial joint, or spinal canal.Type: ApplicationFiled: October 19, 2015Publication date: February 11, 2016Inventors: Susan J. Drapeau, William F. McKay, Nelson Scarborough
-
Publication number: 20150306275Abstract: In certain described embodiments, implantable medical materials comprise a scaffolding material, a liquid organic binder, and entrapped calcium-containing particles. The medical materials can incorporate an osteoinductive factor such as a protein. The scaffolding material can bind the factor. In additional described embodiments, implantable medical materials include an osteoconductive scaffolding material, an incorporated osteoinductive factor, and a biodegradable barrier material effective to delay release of the factor from the scaffolding material. The scaffolding material can bind the factor. Also described a methods for preparing and implanting the described medical materials.Type: ApplicationFiled: May 15, 2015Publication date: October 29, 2015Inventors: Jeffrey M. Gross, Steve Peckham, Jeffrey L. Scifert, Jeffrey Badura, Nelson Scarborough, Scott Vickers
-
Patent number: 9161903Abstract: Flowable compositions and methods are provided for delivering a therapeutic agent at or near a target tissue site beneath the skin of a patient, the flowable composition comprising (i) a solvent and (ii) an effective amount of the therapeutic agent, the flowable composition being capable of hardening to form a drug depot at a physiological temperature or as solvent contacts bodily fluid at or near the target tissue site, wherein the drug depot is capable of releasing the therapeutic agent over a period of at least one day and the target tissue site comprises at least one muscle, ligament, tendon, cartilage, spinal disc, spinal foraminal space near the spinal nerve root, facet or synovial joint, or spinal canal.Type: GrantFiled: October 31, 2008Date of Patent: October 20, 2015Assignee: Warsaw Orthopedic, Inc.Inventors: Susan J. Drapeau, William F. McKay, Nelson Scarborough
-
Patent number: 9056150Abstract: In certain described embodiments, implantable medical materials comprise a scaffolding material, a liquid organic binder, and entrapped calcium-containing particles. The medical materials can incorporate an osteoinductive factor such as a protein. The scaffolding material can bind the factor. In additional described embodiments, implantable medical materials include an osteoconductive scaffolding material, an incorporated osteoinductive factor, and a biodegradable barrier material effective to delay release of the factor from the scaffolding material. The scaffolding material can bind the factor. Also described a methods for preparing and implanting the described medical materials.Type: GrantFiled: December 4, 2007Date of Patent: June 16, 2015Assignee: Warsaw Orthopedic, Inc.Inventors: Jeffrey M. Gross, Steve Peckham, Jeffrey Scifert, Jeffrey Badura, Nelson Scarborough, Scott Vickers
-
Patent number: 8753689Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: GrantFiled: September 9, 2013Date of Patent: June 17, 2014Assignee: Warsaw Orthopedic, Inc.Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Publication number: 20140010891Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: ApplicationFiled: September 9, 2013Publication date: January 9, 2014Applicant: WARSAW ORTHOPEDIC. INC.Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Patent number: 8529962Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: GrantFiled: January 20, 2011Date of Patent: September 10, 2013Assignee: Warsaw Orthopedic, Inc.Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Publication number: 20120273548Abstract: A monitoring system is disclosed for in vivo monitoring of preselected physiological parameters associated with acute and/or chronic tissue compromise or failure in one or multiple tissue/organ sites in real time. In one method, a body portion of a surgical stapling device is positioned adjacent a first tissue section, an anvil assembly adapted to engage the body portion is positioned adjacent a second tissue section, and a monitoring device is positioned adjacent the first and/or second tissue sections. The monitoring device includes a sensor adapted to measure a preselected physiological parameter and a transmitter for transmitting signal to an extracorporeal receiving unit. The surgical stapling device is fired to mechanically secure the first and second tissue sections with at least one staple and the preselected physiological parameter is monitored via the information transmitted from the monitoring device to the receiving unit.Type: ApplicationFiled: April 3, 2012Publication date: November 1, 2012Inventors: Yong Ma, Nelson Scarborough, Marisha Godek, Rohan Shah, James Power, Nilay Mukherjee, Frank Viola, Edward Mckenna, Shannon Campbell
-
Publication number: 20120065594Abstract: A fluid introduction system includes an introducer configured to create a pressure of at least 69 kPa within a spine, and an operator configured to actuate the introducer to introduce fluid into the spine according to a predetermined fluid introduction profile. The system can include a computer readable medium having code for receiving fluid introduction data indicative of a fluid introduction parameter, and for receiving response data indicative of a response of the patient at a time related to a time of the fluid introduction data. A method for introducing fluid includes positioning a first introducer in a first portion of a spine, positioning a second introducer in a second, different portion of the spine and, without removing the first and second introducers, introducing fluid into the first portion of the spine with the first introducer and introducing fluid into the second portion of the spine with the second introducer.Type: ApplicationFiled: September 12, 2011Publication date: March 15, 2012Applicant: NEUROTHERM, INC.Inventors: Nelson SCARBOROUGH, John V. HAMILTON, Andy H. UCHIDA, Ralph I. MCNALL, Steven LEPKE
-
Patent number: 8123707Abstract: The invention relates to methods and apparatus for therapeutically treating connective tissue or increasing vascularization in tissue using ultrasound. More particularly, the present invention relates to methods and apparatus which use ultrasound to stimulate growth or healing, or to treating pathologies, of connective tissue, or to increase vascularization in ischaemic or grafted tissue using ultrasound.Type: GrantFiled: June 18, 2010Date of Patent: February 28, 2012Assignee: Exogen, Inc.Inventors: James William Huckle, Andrew Carter, Nicolas J. Cotton, William R Walsh, Nelson Scarborough, Roger J. Talish
-
Publication number: 20110108644Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: ApplicationFiled: January 20, 2011Publication date: May 12, 2011Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Patent number: 7939108Abstract: Demineralized bone particles are obtained by demineralizing whole bone and thereafter subdividing the demineralized bone to provide the demineralized bone particles.Type: GrantFiled: December 5, 2007Date of Patent: May 10, 2011Inventors: John W. Morris, Lawrence A. Shimp, Kenneth C. Petersen, Albert Manrique, David Kaes, Nelson Scarborough, Michael Dowd
-
Publication number: 20100318003Abstract: The invention relates to methods and apparatus for therapeutically treating connective tissue or increasing vascularization in tissue using ultrasound. More particularly, the present invention relates to methods and apparatus which use ultrasound to stimulate growth or healing, or to treating pathologies, of connective tissue, or to increase vascularization in ischaemic or grafted tissue using ultrasound.Type: ApplicationFiled: June 18, 2010Publication date: December 16, 2010Applicant: EXOGEN, INC.Inventors: James William Huckle, Andrew J. Carter, Nicolas J. Cotton, William R. Walsh, Nelson Scarborough, Roger Talish